Researchers and journalists have found innovative ways to measure Russia’s ability to keep fighting.
Merck says Keytruda injection on par with approved IV version in trial
Merck said a study showed its injectable version of cancer drug Keytruda was not inferior to the currently approved intravenous formulation of its treatment.